Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

NASDAQ:SBC - Nasdaq - US73245B1070 - Common Stock - Currency: USD

4.93  -0.07 (-1.4%)

After market: 4.93 0 (0%)

Fundamental Rating

6

Overall SBC gets a fundamental rating of 6 out of 10. We evaluated SBC against 103 industry peers in the Health Care Providers & Services industry. SBC has an excellent financial health rating, but there are some minor concerns on its profitability. SBC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SBC was profitable.
SBC had a positive operating cash flow in the past year.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

With an excellent Return On Assets value of 17.34%, SBC belongs to the best of the industry, outperforming 96.12% of the companies in the same industry.
With an excellent Return On Equity value of 21.80%, SBC belongs to the best of the industry, outperforming 88.35% of the companies in the same industry.
The Return On Invested Capital of SBC (28.47%) is better than 97.09% of its industry peers.
Industry RankSector Rank
ROA 17.34%
ROE 21.8%
ROIC 28.47%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin of SBC (24.94%) is better than 100.00% of its industry peers.
SBC has a better Operating Margin (43.00%) than 100.00% of its industry peers.
SBC has a better Gross Margin (77.94%) than 92.23% of its industry peers.
Industry RankSector Rank
OM 43%
PM (TTM) 24.94%
GM 77.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SBC has less shares outstanding
The debt/assets ratio for SBC has been reduced compared to a year ago.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SBC has an Altman-Z score of 8.69. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.69, SBC belongs to the best of the industry, outperforming 93.20% of the companies in the same industry.
SBC has a debt to FCF ratio of 0.56. This is a very positive value and a sign of high solvency as it would only need 0.56 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.56, SBC belongs to the best of the industry, outperforming 89.32% of the companies in the same industry.
SBC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
SBC's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. SBC outperforms 79.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.56
Altman-Z 8.69
ROIC/WACC3.21
WACC8.87%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 4.44 indicates that SBC has no problem at all paying its short term obligations.
SBC has a better Current ratio (4.44) than 93.20% of its industry peers.
SBC has a Quick Ratio of 4.40. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
SBC's Quick ratio of 4.40 is amongst the best of the industry. SBC outperforms 93.20% of its industry peers.
Industry RankSector Rank
Current Ratio 4.44
Quick Ratio 4.4
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 383.61% over the past year.
The Revenue has grown by 261.14% in the past year. This is a very strong growth!
EPS 1Y (TTM)383.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.16%
Revenue 1Y (TTM)261.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.65%

3.2 Future

Based on estimates for the next years, SBC will show a small growth in Earnings Per Share. The EPS will grow by 1.25% on average per year.
Based on estimates for the next years, SBC will show a small growth in Revenue. The Revenue will grow by 1.15% on average per year.
EPS Next Y0%
EPS Next 2Y1.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.42%
Revenue Next 2Y1.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.72, the valuation of SBC can be described as reasonable.
Based on the Price/Earnings ratio, SBC is valued cheaper than 87.38% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.18, SBC is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.00, the valuation of SBC can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 93.20% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, SBC is valued rather cheaply.
Industry RankSector Rank
PE 10.72
Fwd PE 8
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SBC is valued cheaper than 93.20% of the companies in the same industry.
SBC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 33.24
EV/EBITDA 4.38
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SBC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (7/15/2025, 8:21:21 PM)

After market: 4.93 0 (0%)

4.93

-0.07 (-1.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)09-21 2025-09-21
Inst Owners0.09%
Inst Owner ChangeN/A
Ins Owners89.47%
Ins Owner Change0%
Market Cap510.80M
AnalystsN/A
Price Target6.13 (24.34%)
Short Float %2.04%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.84%
Min EPS beat(2)10.66%
Max EPS beat(2)89.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.84%
Min Revenue beat(2)-22.64%
Max Revenue beat(2)-9.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.17%
PT rev (3m)-39.9%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)-15.62%
EPS NY rev (1m)32.22%
EPS NY rev (3m)-16.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 10.72
Fwd PE 8
P/S 2.58
P/FCF 33.24
P/OCF 27.13
P/B 2.26
P/tB 2.32
EV/EBITDA 4.38
EPS(TTM)0.46
EY9.33%
EPS(NY)0.62
Fwd EY12.5%
FCF(TTM)0.15
FCFY3.01%
OCF(TTM)0.18
OCFY3.69%
SpS1.91
BVpS2.19
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.34%
ROE 21.8%
ROCE 36.04%
ROIC 28.47%
ROICexc 64.59%
ROICexgc 68.77%
OM 43%
PM (TTM) 24.94%
GM 77.94%
FCFM 7.76%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.56
Debt/EBITDA 0.08
Cap/Depr 101.52%
Cap/Sales 1.75%
Interest Coverage 2701.71
Cash Conversion 21.27%
Profit Quality 31.14%
Current Ratio 4.44
Quick Ratio 4.4
Altman-Z 8.69
F-Score6
WACC8.87%
ROIC/WACC3.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)383.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.16%
EPS Next Y0%
EPS Next 2Y1.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)261.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.65%
Revenue Next Year-9.42%
Revenue Next 2Y1.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y268.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1908.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2315.21%
OCF growth 3YN/A
OCF growth 5YN/A